Asset Details
Do you wish to reserve the book?
Standard treatment in advanced ovarian cancer in 2005: the state of the art
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Standard treatment in advanced ovarian cancer in 2005: the state of the art
Do you wish to request the book?
Standard treatment in advanced ovarian cancer in 2005: the state of the art
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Standard treatment in advanced ovarian cancer in 2005: the state of the art
2005
Overview
. Bookman MA. Standard treatment in advanced ovarian cancer in 2005: the state of the art. Int J Gynecol Cancer 2005;15(Suppl. 3):212–220. What are standards? The oncology community expends considerable effort to review the results from definitive treatment studies and define recommendations for future studies, as well as standards of care for the community and patients who are not participating in clinical trials. This is a thoughtful and well‐intentioned process but subject to considerable bias due to limitations in the data and/or their interpretation. While ovarian cancer is highly responsive to platinum‐based therapy after initial cytoreductive surgery, there is a substantial risk of recurrence, which is accompanied by the emergence of drug‐resistant disease. Better treatments with improved long‐term outcomes are needed. From this perspective, standards can help to provide a baseline for assessing gaps in our current knowledge and defining priorities for future clinical trials. While not an exhaustive review, this study will focus on key clinical concepts that are guiding ovarian cancer research and treatment.
Publisher
Blackwell Science Inc
Subject
Antineoplastic Combined Chemotherapy Protocols - administration & dosage
/ Antineoplastic Combined Chemotherapy Protocols - standards
/ Female
/ Gynecologic Surgical Procedures
/ Humans
/ Neoplasms, Glandular and Epithelial - pathology
/ Neoplasms, Glandular and Epithelial - therapy
/ Ovarian Neoplasms - pathology
/ Platinum Compounds - administration & dosage
/ Platinum Compounds - standards
